Leprosy (Hansen's Disease): Causes, Modern Treatment, and Ending Stigma
Leprosy (Hansen's disease) is a chronic infectious disease caused by Mycobacterium leprae or Mycobacterium lepromatosis. It primarily affects the skin, peripheral nerves, mucosa of the upper respiratory tract, and eyes. Untreated, it can cause progressive nerve damage, skin lesions, and disfigurement.
Terminology Matters
The term "leper" has historically been used to describe a person with leprosy, but it carries profound stigma. Preferred terminology includes "person affected by leprosy" or "individual with Hansen's disease" to promote dignity and reduce discrimination.
Key Facts
- Transmission: Prolonged close contact with untreated individuals via respiratory droplets. Not highly contagious.
- Treatment: Multi-drug therapy (MDT)—dapsone, rifampicin, clofazimine—is highly effective and provided free worldwide by WHO.
- Early diagnosis prevents disability. Nerve damage is irreversible; early treatment stops progression.
Global Status
Leprosy is curable. Global elimination (defined as <1 case per 10,000 population) has been achieved in most countries, but pockets of transmission persist. Combating stigma remains essential for early case detection and treatment adherence.
Leukemia - Related Articles
- Sickle Cell Disease: Mortality Risks, Complications, and Modern Outcomes
- Bone Marrow Transplant Risks: Mortality Rates and Key Complications
- Understanding and Treating Blood Cancers: Options & Approaches
- Why Red Blood Cells Lack a Nucleus: Evolutionary Advantage for Oxygen Transport
- Leukemia: Understanding Causes, Risk Factors & Genetic Mutations
- Red vs. White Blood Cell Counts: Why There Are More RBCs
- Bone Marrow Color Changes: Causes, Diagnostic Significance, and Clinical Context
